Triatomic Management’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17,000
Closed -$413K 62
2023
Q3
$413K Buy
17,000
+4,000
+31% +$107K 0.29% 41
2023
Q2
$360K Buy
+13,000
New +$425K 0.37% 38
2023
Q1
Sell
-17,710
Closed -$544K 71
2022
Q4
$544K Sell
17,710
-31,893
-64% -$1.01M 0.46% 29
2022
Q3
$1.7M Sell
49,603
-20,132
-29% -$861K 0.98% 20
2022
Q2
$2.42M Buy
69,735
+13,739
+25% +$484K 2.22% 12
2022
Q1
$2.46M Buy
55,996
+29,000
+107% +$1.4M 2% 13
2021
Q4
$1.7M Buy
+26,996
New +$2.29M 1.04% 27

Other funds holding ZLAB

Triatomic Management's ZLAB Position: Q4 2023 in Review

Triatomic Management sold out of Zai Lab (ZLAB) in Q4 2023, closing a stake of 17,000 shares — an estimated $413K sold.

Triatomic Management first reported a position in ZLAB in Q4 2021 and held it in 7 quarters. The position peaked at $2.46M in Q1 2022. 124 funds tracked by Wall St. Rank hold ZLAB as of Q4 2023.

  • Triatomic Management reported no remaining Zai Lab position as of Q4 2023 after selling out during the quarter.
  • Triatomic Management sold 17,000 Zai Lab shares in Q4 2023, an estimated $413K.
  • Triatomic Management first reported a position in Zai Lab in Q4 2021 and held it in 7 quarters.
  • Triatomic Management's Zai Lab position peaked at $2.46M in Q1 2022.
  • 124 funds tracked by Wall St. Rank held Zai Lab as of Q4 2023.

Based on Triatomic Management's 13F filing for Q4 2023, filed 13 Feb 2024.